1. Home
  2. USAS vs NMRA Comparison

USAS vs NMRA Comparison

Compare USAS & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • USAS
  • NMRA
  • Stock Information
  • Founded
  • USAS 1998
  • NMRA 2019
  • Country
  • USAS Canada
  • NMRA United States
  • Employees
  • USAS N/A
  • NMRA N/A
  • Industry
  • USAS Metal Mining
  • NMRA
  • Sector
  • USAS Basic Materials
  • NMRA
  • Exchange
  • USAS Nasdaq
  • NMRA Nasdaq
  • Market Cap
  • USAS 286.7M
  • NMRA 287.6M
  • IPO Year
  • USAS N/A
  • NMRA 2023
  • Fundamental
  • Price
  • USAS $0.52
  • NMRA $1.28
  • Analyst Decision
  • USAS Strong Buy
  • NMRA Buy
  • Analyst Count
  • USAS 1
  • NMRA 8
  • Target Price
  • USAS $0.80
  • NMRA $10.14
  • AVG Volume (30 Days)
  • USAS 1.2M
  • NMRA 1.3M
  • Earning Date
  • USAS 03-27-2025
  • NMRA 03-03-2025
  • Dividend Yield
  • USAS N/A
  • NMRA N/A
  • EPS Growth
  • USAS N/A
  • NMRA N/A
  • EPS
  • USAS N/A
  • NMRA N/A
  • Revenue
  • USAS $97,123,000.00
  • NMRA N/A
  • Revenue This Year
  • USAS $21.84
  • NMRA N/A
  • Revenue Next Year
  • USAS $46.00
  • NMRA N/A
  • P/E Ratio
  • USAS N/A
  • NMRA N/A
  • Revenue Growth
  • USAS 14.33
  • NMRA N/A
  • 52 Week Low
  • USAS $0.20
  • NMRA $1.26
  • 52 Week High
  • USAS $0.60
  • NMRA $17.19
  • Technical
  • Relative Strength Index (RSI)
  • USAS 53.97
  • NMRA 26.96
  • Support Level
  • USAS $0.45
  • NMRA $1.26
  • Resistance Level
  • USAS $0.56
  • NMRA $1.48
  • Average True Range (ATR)
  • USAS 0.04
  • NMRA 0.13
  • MACD
  • USAS 0.00
  • NMRA 0.08
  • Stochastic Oscillator
  • USAS 69.00
  • NMRA 4.44

About USAS Americas Gold and Silver Corporation no par value

Americas Gold And Silver Corp is a mining company engaged in the acquisition, exploration, development, and production of precious metals mineral properties in Mexico and the United States. The company's primary operating assets are The Cosala operations, The Galena Complex, and Relief Canyon. The company also holds interests in the San Felipe Development Project located in Sonora, Mexico. It has geographic focus is the Western Hemisphere, particularly the United States and Mexico.

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has rapidly scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. The company expects to continue to progress in the development of its pipeline with the planned initiation of multiple clinical trials across its programs over the next 12 to 18 months, which supports numerous anticipated data readouts.

Share on Social Networks: